Safety of proprotein convertase subtilisin/kexin 9 inhibitors: a systematic review and meta-analysis

Li, J; Du, HY; Wang, Y; Aertgeerts, B; Guyatt, G; Hao, QK; Shen, YJ; Li, L; Su, N; Delvaux, N; Bekkering, G; Khan, SU; Riaz, IB; Vandvik, PO; Su, BH; Tian, HM; Li, SY

Li, SY (通讯作者)，Sichuan Univ, Dept Endocrinol & Metab, West China Hosp, Chengdu, Sichuan, Peoples R China.

HEART, 2022; 108 (16): 1296

Abstract

Objective To determine the harms of proprotein convertase subtilisin/kexin 9 (PCSK9) inhibitors in people who need lipid-lowering therapy. Methods Thi......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索